New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
08:20 EDTCBIChicago Bridge & Iron shares should be bought, says Sterne Agee
Sterne Agee believes that Chicago Bridge & Iron finished 2012 on a strong note and recommends buying the stock ahead of the company's March 28 investor meeting. The firm raised its target on the shares to $60 from $56 and maintains a Buy rating.
News For CBI From The Last 14 Days
Check below for free stories on CBI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
09:50 EDTCBIActive equity options trading on open
Subscribe for More Information
July 30, 2014
16:47 EDTCBIChicago Bridge & Iron announces contract for LNG export facility
Subscribe for More Information
July 29, 2014
10:09 EDTCBIChicago Bridge & Iron call activity attributed to takeover speculation
Subscribe for More Information
10:01 EDTCBIRumor: Chicago Bridge & Iron strength attributed to takeover speculation
July 25, 2014
13:03 EDTCBIPrescience Point keeps Strong Sell on Chicago Bridge & Iron
Subscribe for More Information
July 24, 2014
18:45 EDTCBIOn The Fly: After Hours Movers
Subscribe for More Information
16:28 EDTCBIChicago Bridge & Iron says confident in view of 2014 revenue, earnings growth
Subscribe for More Information
16:27 EDTCBIChicago Bridge & Iron reports Q2 EPS ex-items $1.36, consensus $1.28
Subscribe for More Information
08:21 EDTCBIChicago Bridge & Iron and Versalis sign agreement for new technology
Subscribe for More Information
July 23, 2014
10:02 EDTCBIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:00 EDTCBIChicago Bridge & Iron initiated with a Market Perform at Wells Fargo
Subscribe for More Information
July 22, 2014
08:07 EDTCBICB&I and Clariant announce its new plant will begin production in 2015
CB&I and Clariant announced its new Ziegler-Natta polypropylene catalyst production plant in Louisville, Kentucky, is on schedule to begin production in 2015. The plant is part of a long-term strategic partnership between Clariant's Catalysts business unit and CB&I's Lummus Novolen Technology business.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use